The insurance software developer has now raised more than $33m in total, $15.2m coming in a new round featuring MS&AD Ventures.

Merck Group spinoff iOnctura will put the $18.7m it raised in the M Ventures-backed round into a clinical trial for its solid tumour therapy.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Posco Ventures-backed lockscreen advertising publisher Buzzvil has secured funding from consortium Mega-7 Club to boost its overall funding to about $32m.

Intel Capital and Samsung Next both returned for the cyber threat analysis platform's series B round, which was led by OpenView Venture Partners.

3M, CareFirst BlueCross BlueShield, Lafayette General Health, OSF Healthcare and ProMedica all invested as the healthcare technology provider closed an $11.1m round.

University Hospital Tübingen's liver disease treatment spinout HepaRegenix has raised $21.6m in all following a series B round that featured Novo and Boehringer Ingelheim.

SoftBank has led a $103m series B round for the IoT network and hub developer, a spinout of Stanford, that made up one of two rounds it has raised.

University Hospital Tübingen's liver disease treatment spinout HepaRegenix has raised $21.6m in all following a series B round that will fund trials of its first candidate.

SoftBank led a $103m series B round for the internet-of-things network and hub developer that made up one of two rounds it has raised.